WOCKHARDT Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WOCKHARDT, and what generic and branded alternatives to WOCKHARDT drugs are available?
WOCKHARDT has one hundred and seven approved drugs.
There are three tentative approvals on WOCKHARDT drugs.
Summary for WOCKHARDT
US Patents: | 0 |
Tradenames: | 84 |
Ingredients: | 77 |
NDAs: | 107 |
Patent Litigation for WOCKHARDT: | See patent lawsuits for WOCKHARDT |
PTAB Cases with WOCKHARDT as petitioner: | See PTAB cases with WOCKHARDT as petitioner |
Drugs and US Patents for WOCKHARDT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wockhardt | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065197-003 | Jun 20, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wockhardt | METAPROTERENOL SULFATE | metaproterenol sulfate | SOLUTION;INHALATION | 075586-002 | May 30, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wockhardt | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 077941-001 | Mar 22, 2007 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wockhardt Ltd | CARBIDOPA, LEVODOPA AND ENTACAPONE | carbidopa; entacapone; levodopa | TABLET;ORAL | 090833-002 | Nov 20, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wockhardt | TOPIRAMATE | topiramate | TABLET;ORAL | 090353-002 | Sep 1, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Wockhardt Bio Ag | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 091231-002 | Jan 19, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.